Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C12H8N2O |
| Molecular Weight | 196.2047 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=CC=CC2=NC3=C(C=CC=C3)N=C12
InChI
InChIKey=SVRNCBGWUMMBQB-UHFFFAOYSA-N
InChI=1S/C12H8N2O/c15-11-7-3-6-10-12(11)14-9-5-2-1-4-8(9)13-10/h1-7,15H
| Molecular Formula | C12H8N2O |
| Molecular Weight | 196.2047 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Generation of Reactive Oxygen Species Mediated by 1‑Hydroxyphenazine, a Virulence Factor of Pseudomonas aeruginosa. | 2015-02-16 |
|
| Scarless and sequential gene modification in Pseudomonas using PCR product flanked by short homology regions. | 2010-08-03 |
|
| Metabolism and function of phenazines in bacteria: impacts on the behavior of bacteria in the environment and biotechnological processes. | 2010-05 |
|
| Inflammatory mechanisms in the lung. | 2009 |
|
| Cell wall glycans and soluble factors determine the interactions between the hyphae of Candida albicans and Pseudomonas aeruginosa. | 2008-10 |
|
| Redox reactions of phenazine antibiotics with ferric (hydr)oxides and molecular oxygen. | 2008-04-01 |
|
| Widespread pyocyanin over-production among isolates of a cystic fibrosis epidemic strain. | 2007-05-23 |
|
| State of the art: why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection? | 2003 |
|
| Induction of neutrophil apoptosis by the Pseudomonas aeruginosa exotoxin pyocyanin: a potential mechanism of persistent infection. | 2002-02-15 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:21:33 GMT 2025
by
admin
on
Mon Mar 31 21:21:33 GMT 2025
|
| Record UNII |
0D51M21IXN
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
0D51M21IXN
Created by
admin on Mon Mar 31 21:21:33 GMT 2025 , Edited by admin on Mon Mar 31 21:21:33 GMT 2025
|
PRIMARY | |||
|
88882
Created by
admin on Mon Mar 31 21:21:33 GMT 2025 , Edited by admin on Mon Mar 31 21:21:33 GMT 2025
|
PRIMARY | |||
|
m5950
Created by
admin on Mon Mar 31 21:21:33 GMT 2025 , Edited by admin on Mon Mar 31 21:21:33 GMT 2025
|
PRIMARY | Merck Index | ||
|
135412648
Created by
admin on Mon Mar 31 21:21:33 GMT 2025 , Edited by admin on Mon Mar 31 21:21:33 GMT 2025
|
PRIMARY | |||
|
DTXSID70871744
Created by
admin on Mon Mar 31 21:21:33 GMT 2025 , Edited by admin on Mon Mar 31 21:21:33 GMT 2025
|
PRIMARY | |||
|
62216
Created by
admin on Mon Mar 31 21:21:33 GMT 2025 , Edited by admin on Mon Mar 31 21:21:33 GMT 2025
|
PRIMARY | |||
|
528-71-2
Created by
admin on Mon Mar 31 21:21:33 GMT 2025 , Edited by admin on Mon Mar 31 21:21:33 GMT 2025
|
PRIMARY |